Skip to main content
Veterinary Medicines

RISPOVAL Pasteurella

Authorised
  • Mannheimia haemolytica, serotype A1, strain NL 1009, capsular antigen
  • Mannheimia haemolytica, serotype A1, strain NL 1009, leucotoxoid

Product identification

Medicine name:
RISPOVAL Pasteurella
Active substance:
  • Mannheimia haemolytica, serotype A1, strain NL 1009, capsular antigen
  • Mannheimia haemolytica, serotype A1, strain NL 1009, leucotoxoid
Target species:
  • Cattle
Route of administration:
  • Intramuscular use
  • Subcutaneous use

Product details

Active substance and strength:
  • Mannheimia haemolytica, serotype A1, strain NL 1009, capsular antigen
    345.00
    enzyme-linked immunosorbent assay unit
    /
    1.00
    Dose
  • Mannheimia haemolytica, serotype A1, strain NL 1009, leucotoxoid
    200.00
    enzyme-linked immunosorbent assay unit
    /
    1.00
    Dose
Pharmaceutical form:
  • Lyophilisate and solvent for suspension for injection
Withdrawal period by route of administration:
  • Intramuscular use
    • Cattle
      • Meat and offal
        0
        day
      • Milk
        0
        day
  • Subcutaneous use
    • Cattle
      • Meat and offal
        0
        day
      • Milk
        0
        day
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QI02AB04
Authorisation status:
  • Valid
Authorised in:
  • Germany
Available in:
  • Germany
Package description:

Additional information

Entitlement type:
  • Marketing Authorisation
Marketing authorisation holder:
  • Zoetis Deutschland GmbH
Marketing authorisation date:
Manufacturing sites for batch release:
  • Zoetis Belgium
Responsible authority:
  • Paul-Ehrlich-Institut
Authorisation number:
  • 322a/94
Date of authorisation status change:

Documents

Combined File of all Documents

This document does not exist in this language (English). You can find it in another language below.
German (PDF)
Published on: 31/10/2025